[Featured Stock] Itron Surges 14.39% on Russian Vaccine Investment

[Asia Economy Reporter Park Soyeon] Etron, which invested in the Russian Sputnik V vaccine, is showing strong performance.

As of 9:17 AM on the 4th in the KOSDAQ market, Etron is trading at 318 won, up 40 won (14.39%) from the previous day.

The Sputnik V vaccine is the only vaccine that can be distributed at room temperature (2°C to 8°C) and is relatively affordable, priced below 20 dollars.

The Russian vaccine Sputnik V is being produced domestically by Korea Corus. Etron and EID have invested a total of 20 billion won in Korea Corus. Korea Corus has decided to produce 150 million doses of the Russian vaccine.

Russia began domestic vaccinations with Sputnik V as early as December last year, and about 50 countries worldwide have pre-ordered the Russian vaccine. Among them, 12 countries including Algeria, Hungary, Iran, and Venezuela are expected to start Sputnik V vaccinations.

Meanwhile, German Chancellor Merkel also hinted at the introduction of Sputnik V following news of the vaccine's phase 3 trials, and the European Union (EU) approval process is currently underway.